loader
Please Wait
Applying Filters...

Evonik Evonik

X

Information, Expiry & Status of FDA Orange Book Patents covering Dexlansoprazole

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 TAKEDA PHARMS USA (40)

filter

01 7790755 (2)

02 7790755*PED (2)

03 8105626 (2)

04 8105626*PED (2)

05 8173158 (6)

06 8173158*PED (2)

07 8461187 (3)

08 8461187*PED (3)

09 8722084*PED (2)

10 8784885*PED (3)

11 8871273 (3)

12 8871273*PED (1)

13 9011926 (3)

14 9233103 (2)

15 9238029 (3)

16 9241910 (1)

filter

01 Blank (40)

filter

01 Y (17)

02 Blank (23)

filter

01 2024-04-15 (5)

02 2026-01-17 (6)

03 2026-02-24 (3)

04 2026-07-17 (3)

05 2026-08-02 (2)

06 2026-09-27 (2)

07 2027-02-02 (2)

08 2027-03-27 (2)

09 2028-01-11 (3)

10 2028-07-11 (1)

11 2029-03-10 (1)

12 2030-03-17 (6)

13 2030-09-17 (2)

14 2032-03-05 (2)

URL Supplier Web Content
8173158
2030-03-17
U-951
22287
TREATMENT OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (GERD) FOR 4 WEEKS
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8173158
2030-03-17
U-949
22287
HEALING OF ALL GRADES OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 8 WEEKS
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8173158
2030-03-17
U-951
22287
TREATMENT OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GASTROESOPHAGEAL REFLUX DISEASE (GERD) FOR 4 WEEKS
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8173158
2030-03-17
U-950
22287
MAINTAIN HEALING OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 6 MONTHS
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8173158
2030-03-17
U-949
22287
HEALING OF ALL GRADES OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 8 WEEKS
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9233103
2032-03-05
U-1805
22287
USE OF DEXLANSOPRAZOLE IN PATIENTS TAKING CLOPIDOGREL WITHOUT MEANINGFUL CYP2C19 INTERACTIONS
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9233103
2032-03-05
U-1805
22287
USE OF DEXLANSOPRAZOLE IN PATIENTS TAKING CLOPIDOGREL WITHOUT MEANINGFUL CYP2C19 INTERACTIONS
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8173158
2030-03-17
U-950
22287
MAINTAIN HEALING OF EROSIVE ESOPHAGITIS (EE) FOR UP TO 6 MONTHS
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9011926
Y
2026-02-24
22287
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
7790755
Y
2026-08-02
22287
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY